Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-02-25
    E.g., 2018-02-25

Articles

11899 items
6:00 AM, Feb 15, 2018  |  BC Extra | Financial News

Celularity unveils size of series A

Celularity Inc. (Warren, N.J.) revealed on Thursday that it has raised more than $250 million in series A funding and assets from Celgene Corp. (NASDAQ:CELG), three other biotechs and private investors. The cell therapy, regenerative...
2:28 PM, Feb 13, 2018  |  BC Extra | Financial News

Catalyst prices $100M follow-on

Catalyst Biosciences Inc. (NASDAQ:CBIO) raised $100 million through the sale of 2.9 million shares at $34 in a follow-on underwritten by JonesTrading Institutional Services, Ladenburg Thalmann, LifeSci Capital and B. Riley FBR. The price is...
4:08 PM, Feb 12, 2018  |  BC Extra | Financial News

DiaCarta closes $45M series B

Molecular diagnostics company DiaCarta Inc. (Hayward, Calif.) said it completed a $45 million series B round. The round’s second close, announced Monday, was led by Fortune Foundation Capital with participation from Good Health Capital. The...
4:08 PM, Feb 12, 2018  |  BC Extra | Financial News

Biotech indexes rise

Biotech indexes rose on Monday as the broader markets climbed for a second straight day. The NASDAQ Biotechnology Index (NBI), NYSE Arca Biotechnology Index (BTK) and BioCentury 100 each gained about 2%, as did the...
4:56 PM, Feb 09, 2018  |  BC Extra | Financial News

Biotech index gains erased, fund flows into the red

The return of drug pricing rhetoric and global stock market volatility have rocked biotech indexes over the last two weeks, wiping out most of what had been strong year-to-date gains. Fund flows into the space...
3:48 PM, Feb 09, 2018  |  BC Extra | Financial News

InnoCare raises $55M

InnoCare Pharma Ltd. (Beijing, China) raised $55 million in a financing led by Vivo Capital. Existing investor Jianxin Capital also participated. InnoCare is developing through R&D and in-licensing a pipeline of immune-modulating therapies to treat autoimmune...
10:54 AM, Feb 09, 2018  |  BC Extra | Financial News

Sage prices $575M follow-on

Sage Therapeutics Inc. (NASDAQ:SAGE) raised $575 million late Thursday through the sale of 3.5 million shares at $164 in a follow-on underwritten by J.P. Morgan, Goldman Sachs, Morgan Stanley, Cowen, RBC and BMO Capital Markets....
5:33 PM, Feb 08, 2018  |  BC Extra | Financial News

Biotech tumbles with markets

Biotech indexes fell on Thursday as the broader markets stumbled into correction territory. The NASDAQ Biotechnology Index (NBI) and NYSE Arca Biotechnology Index (BTK) dropped 4%, as did the Dow Jones Industrial Average, NASDAQ Composite...
2:29 PM, Feb 08, 2018  |  BC Extra | Financial News

Rani raises $53M series D round

Rani Therapeutics LLC (San Jose, Calif.) raised $53 million in a series D round. New investors GeneScience Pharmaceuticals Co. Ltd. (Changchun, China), Shire plc (LSE:SHP; NASDAQ:SHPG), Bossa Ventures and Cathay Venture participated, as did existing...
12:19 PM, Feb 08, 2018  |  BC Extra | Financial News

Evolus slips after $60M IPO

Evolus Inc. (NASDAQ:EOLS) dipped $0.40 to $11.60 in its first day of trading Thursday after raising $60 million through the sale of 5 million shares at $12 in an IPO underwritten by Cantor Fitzgerald, Mizuho,...

Pages